Market Overview:
The global organs-on-chips market is expected to grow at a CAGR of 16.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing demand for organ-on-chip technology for drug discovery and toxicology research applications. Additionally, the growing awareness about organ donation and transplantation is also contributing to the growth of this market. However, high costs associated with the development and deployment of organ-on-chip technology are restraining its growth in certain regions such as North America and Europe. The global organs-on-chips market can be segmented on the basis of type into heart, liver, lung, and other organs. The liver segment is expected to account for a major share of the global organs-on -chips market during the forecast period owing to its high adoption rate for drug discovery and toxicology research applications. On the basis of application,the global organs - on - chipsmarket can be divided into drug discovery, toxicology research ,and other applications . Drug discovery accounted for a major shareof th eglobal orga ns - on - chip s marke t in 2017 an d i s projected t o maintain its lead du ring th eforecast per iod . Oth er app licatio ns includ e researc h o n diseas es suc h as cancer an d Alzheimers disease .
 Industry Outlook.svg)
Product Definition:
An organ-on-a-chip (OOC) is a device that reproduces the function of an organ on a microchip. The importance of OOCs is that they can be used to study the effects of drugs and other treatments on organs, without using live animals or human patients.
Heart:
The global heart, it's usage and growth factor in organs-on-chips (OOC) market size was valued at USD 1.1 billion in 2016 and is expected to grow at a CAGR of XX% over the forecast period. The increasing prevalence of chronic diseases such as cardiovascular disorders, diabetes, obesity & respiratory diseases coupled with rising demand for minimally invasive surgeries are some major factors driving the growth of this market globally.
Liver:
The liver is a vital organ located in the upper right portion of the body. It helps in processing and removing toxins from the blood and helps maintain healthy functions of other organs. The growing global base of geriatric population is expected to be one of the key drivers for market growth as aging individuals are more prone to develop diseases such as cirrhosis or cancer affecting this organ.
Application Insights:
The other applications segment dominated the global organs-on-chips market in 2017 and is expected to witness significant growth over the forecast period. The toxicology research segment is also expected to exhibit considerable growth during the same period owing to an increase in toxicity studies on animals. This has resulted in a rise in demand for OOC models that are used for toxicology testing on rodents and rabbits, which further fuels market growth.
Drug discovery was the largest application of OOCs and accounted for over 40% of total revenue generated by this segment in 2017 due largely to their ability to mimic human body functions such as metabolism, transport, drug action & interaction with target cells/organs within a laboratory setting at reduced costs when compared with traditional methods used across various industries such as pharmaceutical or food & beverage etc. Henceforth, increasing R&D activities pertaining towards new drug development are anticipated fuel product demand during the forecast period.
Regional Analysis:
North America dominated the global market in 2017. The presence of a large number of pharmaceutical and biopharmaceutical companies, coupled with high research funding for the development of novel therapies, is expected to drive growth over the forecast period. In addition, increasing demand for transplantable organs from a growing aging population is anticipated to propel market growth during the forecast period.
Asia Pacific region is anticipated to witness lucrative CAGR over the forecast period owing to factors such as improving healthcare infrastructure and rising patient awareness regarding organ donation activities in this region. Moreover, government initiatives encouraging people donate organs are also expected to boost regional product demand during 2018-2030 time frame. For instance; Organ Donation India promotes voluntary donations by providing information about organ donation and its importance through mass media campaigns across India (Organ Donor Programme). Such government initiatives are also carried out in Australia (Donate Life) and New Zealand (Organdonation).
Growth Factors:
- Increasing demand for organ transplants: The increasing demand for organ transplants is one of the major growth drivers for the organs-on-chips market. According to the World Health Organization (WHO), there are more than 120,000 patients waiting for an organ transplant in the U.S., and this number is only increasing with time. This growing demand is expected to drive the adoption of organs-on-chips technology as it can help reduce wait times for patients and also improve transplant success rates.
- Advances in 3D printing technology: The advances in 3D printing technology are another major growth driver for the organs-on-chips market as they enable researchers to create accurate replicas of human organs using a variety of materials such as plastic, metal, and ceramic. This helps researchers study complex biological systems more effectively and also reduces costs associated with traditional animal testing methods.
- Growing investment in research & development: The growing investment in research & development by private companies and government organizations is another key factor driving growth of the organs-on-chips market worldwide. For instance, In 2014, Johnson & Johnson announced that it would be investing USD 300 million over five years into its JLABS initiative which focuses on accelerating early stage life science innovation including work on Organs on Chips technologies . Such investments are expected to result in increased adoption of this technology across various industries worldwide over time span..
Scope Of The Report
Report Attributes
Report Details
Report Title
Organs-on-chips (OOC) Market Research Report
By Type
Heart, Liver, Lung, Other Organs
By Application
Drug Discovery, Toxicology Research, Other Applications
By Companies
AxoSim, BioIVT, Emulate, Elveflow, MIMETAS, Nortis, Hurel Corporation, InSphero, Tara Biosystems, TissUse
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
148
Number of Tables & Figures
104
Customization Available
Yes, the report can be customized as per your need.
Global Organs-on-chips (OOC) Market Report Segments:
The global Organs-on-chips (OOC) market is segmented on the basis of:
Types
Heart, Liver, Lung, Other Organs
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Drug Discovery, Toxicology Research, Other Applications
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- AxoSim
- BioIVT
- Emulate
- Elveflow
- MIMETAS
- Nortis
- Hurel Corporation
- InSphero
- Tara Biosystems
- TissUse
 Market Overview.svg)
Highlights of The Organs-on-chips (OOC) Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Heart
- Liver
- Lung
- Other Organs
- By Application:
- Drug Discovery
- Toxicology Research
- Other Applications
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Organs-on-chips (OOC) Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
 Market Statistics.svg)
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
OOC is a technology that uses organs-on-chips to help people with organ failure. The chips are inserted into the body through a small incision, and they monitor the health of the organ. If there is an issue with the organ, the chip can send information about it to doctors so that they can take action.
Some of the key players operating in the organs-on-chips (ooc) market are AxoSim, BioIVT, Emulate, Elveflow, MIMETAS, Nortis, Hurel Corporation, InSphero, Tara Biosystems, TissUse.
The organs-on-chips (ooc) market is expected to grow at a compound annual growth rate of 16.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Organs-on-chips (OOC) Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Organs-on-chips (OOC) Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Organs-on-chips (OOC) Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Organs-on-chips (OOC) Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Organs-on-chips (OOC) Market Size & Forecast, 2020-2028
4.5.1 Organs-on-chips (OOC) Market Size and Y-o-Y Growth
4.5.2 Organs-on-chips (OOC) Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Heart
5.2.2 Liver
5.2.3 Lung
5.2.4 Other Organs
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Drug Discovery
6.2.2 Toxicology Research
6.2.3 Other Applications
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Organs-on-chips (OOC) Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Organs-on-chips (OOC) Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Heart
9.6.2 Liver
9.6.3 Lung
9.6.4 Other Organs
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Drug Discovery
9.10.2 Toxicology Research
9.10.3 Other Applications
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Heart
10.6.2 Liver
10.6.3 Lung
10.6.4 Other Organs
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Drug Discovery
10.10.2 Toxicology Research
10.10.3 Other Applications
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Heart
11.6.2 Liver
11.6.3 Lung
11.6.4 Other Organs
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Drug Discovery
11.10.2 Toxicology Research
11.10.3 Other Applications
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Heart
12.6.2 Liver
12.6.3 Lung
12.6.4 Other Organs
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Drug Discovery
12.10.2 Toxicology Research
12.10.3 Other Applications
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Heart
13.6.2 Liver
13.6.3 Lung
13.6.4 Other Organs
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Drug Discovery
13.10.2 Toxicology Research
13.10.3 Other Applications
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Organs-on-chips (OOC) Market: Competitive Dashboard
14.2 Global Organs-on-chips (OOC) Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 AxoSim
14.3.2 BioIVT
14.3.3 Emulate
14.3.4 Elveflow
14.3.5 MIMETAS
14.3.6 Nortis
14.3.7 Hurel Corporation
14.3.8 InSphero
14.3.9 Tara Biosystems
14.3.10 TissUse
